Comparison between Entero Healthcare Solutions IPO and GPT Healthcare IPO.
Entero Healthcare Solutions IPO is a Mainboard Bookbuilding IPO proposed to list at BSE, NSE while GPT Healthcare IPO is a Mainboard Bookbuilding proposed to list at BSE, NSE.
The total issue size of Entero Healthcare Solutions IPO is up to ₹1,600.00 Cr whereas the issue size of the GPT Healthcare IPO is up to ₹525.14 Cr. The final issue price of Entero Healthcare Solutions IPO is ₹1,258.00 per share and of GPT Healthcare IPO is ₹186.00 per share.
| Entero Healthcare Solutions IPO | GPT Healthcare IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ₹1,195.00 per share | ₹177.00 per share |
| Issue Price (Upper) | ₹1,258.00 per share | ₹186.00 per share |
| Issue Price (Final) | ₹1,258.00 per share | ₹186.00 per share |
| Discount (Retail) | ₹0.00 per share | ₹0.00 per share |
| Discount (Employee) | ₹119.00 per share | |
| Market Lot Size | 11 shares | 80 shares |
| Fresh Issue Size | 79,52,518 shares | 21,50,537 shares |
| Fresh Issue Size (Amount) | up to ₹1,000.31 Cr | up to ₹40.00 Cr |
| OFS Issue Size | 47,67,526 shares | 2,60,82,786 shares |
| OFS Issue Size (Amount) | up to ₹599.69 Cr | up to ₹485.14 Cr |
| Issue Size Total | 1,27,20,044 shares | 2,82,33,323 shares |
| Issue Size Total (Amount) | up to ₹1,600.00 Cr | up to ₹525.14 Cr |
Entero Healthcare Solutions IPO opens on Feb 09, 2024, while GPT Healthcare IPO opens on Feb 22, 2024. The closing date of Entero Healthcare Solutions IPO and GPT Healthcare IPO is Feb 13, 2024, and Feb 26, 2024, respectively.
| Entero Healthcare Solutions IPO | GPT Healthcare IPO | |
|---|---|---|
| Anchor Bid Date | Feb 08, 2024 | Feb 21, 2024 |
| Issue Open | Feb 09, 2024 | Feb 22, 2024 |
| Issue Close | Feb 13, 2024 | Feb 26, 2024 |
| Basis Of Allotment (Tentative) | Feb 14, 2024 | Feb 27, 2024 |
| Initiation of Refunds (Tentative) | Feb 15, 2024 | Feb 28, 2024 |
| Credit of Share (Tentative) | Feb 15, 2024 | Feb 28, 2024 |
| Listing date (Tentative) | Feb 16, 2024 | Feb 29, 2024 |
| Anchor Lockin End date 1 | Mar 15, 2024 | Mar 28, 2024 |
| Anchor Lockin End date 2 | May 14, 2024 | May 27, 2024 |
Entero Healthcare Solutions IPO P/E ratio is 0, as compared to GPT Healthcare IPO P/E ratio of 38.1.
| Entero Healthcare Solutions IPO | GPT Healthcare IPO | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials | Company Financials (Restated Consolidated)
| Company Financials (Restated Consolidated)
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 77.11 | 67.34 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | 52.43 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | 0 | 38.1 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | ₹3021.21 Cr. | ₹1526.22 Cr. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROE | -2.66% | 23.59% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | 6.06% | 26.09% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | 0.45 | 0.39 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EPS | ₹0.00 | ₹4.88 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | -1.86% | 23.77% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
In the Entero Healthcare Solutions IPO Retail Individual Investors (RII) are offered 12,65,500 shares while in GPT Healthcare IPO retail investors are offered 12,65,500 shares. Qualified Institutional Buyers (QIB) are offered 37,96,503 shares in Entero Healthcare Solutions IPO and 56,46,664 shares in GPT Healthcare IPO.
| Entero Healthcare Solutions IPO | GPT Healthcare IPO | |
|---|---|---|
| Anchor Investor Reservation | 56,94,753 shares | 84,69,996 shares |
| Market Maker Reservation | ||
| QIB | 37,96,503 shares | 56,46,664 shares |
| NII | 18,98,251 shares | 42,34,999 shares |
| RII | 12,65,500 shares | 98,81,664 shares |
| Employee | 70,237 shares | |
| Others | ||
| Total | 1,27,25,244 shares | 2,82,33,323 shares |
Entero Healthcare Solutions IPO subscribed 1.53x in total, whereas GPT Healthcare IPO subscribed 8.52x.
| Entero Healthcare Solutions IPO | GPT Healthcare IPO | |
|---|---|---|
| QIB (times) | 2.28x | 17.30x |
| NII (times) | 0.22x | 11.02x |
| Big NII (times) | 0.16x | 11.98x |
| Small NII (times) | 0.33x | 9.09x |
| RII (times) | 1.33x | 2.44x |
| Employee (times) | 1.25x | |
| Other (times) | ||
| Total (times) | 1.53x | 8.52x |
